Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database

Shota Hamada1, Hironobu Tokumasu2, Akira Sato1

  • 1Kyoto University, Kyoto, Japan.

Insights

Japanese children with asthma often receive bronchodilators without anti-inflammatory drugs. Improving asthma management in Japan requires optimizing antiasthma drug prescriptions, especially controller medications.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology
  • Public Health

Background:

  • Asthma management guidelines are globally consistent for children.
  • Significant international variations exist in antiasthma drug prescribing patterns.
  • Controller medication use in pediatric asthma requires further investigation.

Purpose of the Study:

  • To analyze antiasthma drug prescribing trends in Japanese children.
  • To specifically evaluate the use of controller medications for pediatric asthma.
  • To identify potential areas for improvement in asthma pharmacotherapy.

Main Methods:

  • Retrospective cohort study design.
  • Utilized a Japanese administrative claims database.
  • Included preschool-age and school-age children diagnosed with asthma.

Main Results:

  • Leukotriene receptor antagonists were prescribed to approximately 80% of children.
  • Long-acting β-agonists were common in preschoolers (87.6%) but less so in school-aged children (59.6%).
  • Inhaled corticosteroid prescriptions were notably low (8.2% preschool, 16.5% school-age); many children received bronchodilators without anti-inflammatory agents.

Conclusions:

  • Pediatric asthma pharmacotherapy in Japan shows suboptimal use of anti-inflammatory agents.
  • Prescribing patterns indicate a potential gap in controller medication utilization.
  • Optimizing drug prescriptions, particularly anti-inflammatory controllers, could enhance asthma care for children in Japan.

Related Concept Videos

Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K